Theratechnologies Inc
TSX:TH

Watchlist Manager
Theratechnologies Inc Logo
Theratechnologies Inc
TSX:TH
Watchlist
Price: 4.47 CAD -4.89%
Market Cap: 205.5m CAD

Wall Street
Price Targets

TH Price Targets Summary
Theratechnologies Inc

There are no price targets for TH.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Theratechnologies Inc Competitors:
Price Targets
CGON
CG Oncology Inc
70% Upside
IVA
Inventiva SA
253% Upside
FOLD
Amicus Therapeutics Inc
71% Upside
PEB
Pacific Edge Ltd
18% Downside
2142
Hbm Holdings Ltd
1% Upside
FYB
Formycon AG
101% Upside
397030
AprilBio Co Ltd
17% Upside
SLNO
Soleno Therapeutics Inc
125% Upside

Revenue
Forecast

Revenue Estimate
Theratechnologies Inc

For the last 13 years the compound annual growth rate for Theratechnologies Inc's revenue is 14%. The projected CAGR for the next 3 years is 6%.

14%
Past Growth
6%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Theratechnologies Inc

The compound annual growth rate of Theratechnologies Inc's operating income for the next 3 years is 37%.

N/A
Past Growth
37%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

Net Income Estimate
Theratechnologies Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-47%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TH's stock price target?
Not Available

TH doesn't have any price targets made by Wall Street professionals.

What is Theratechnologies Inc's Revenue forecast?
Projected CAGR
6%

For the last 13 years the compound annual growth rate for Theratechnologies Inc's revenue is 14%. The projected CAGR for the next 3 years is 6%.

What is Theratechnologies Inc's Operating Income forecast?
Projected CAGR
37%

The compound annual growth rate of Theratechnologies Inc's operating income for the next 3 years is 37%.

Back to Top